Global and United States Acne Vulgaris Treatment Market Report & Forecast 2023-2028

Report ID: 1838743 | Published Date: Sep 2024 | No. of Page: 106 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
1 Study Coverage
    1.1 Acne Vulgaris Treatment Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Acne Vulgaris Treatment Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Acne Vulgaris Treatment Market Size for the Year 2017-2028
        1.2.2 Global Acne Vulgaris Treatment Market Size for the Year 2017-2028
    1.3 Acne Vulgaris Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Acne Vulgaris Treatment in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Acne Vulgaris Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Acne Vulgaris Treatment Market Dynamics
        1.4.1 Acne Vulgaris Treatment Industry Trends
        1.4.2 Acne Vulgaris Treatment Market Drivers
        1.4.3 Acne Vulgaris Treatment Market Challenges
        1.4.4 Acne Vulgaris Treatment Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Acne Vulgaris Treatment by Type
    2.1 Acne Vulgaris Treatment Market Segment by Type
        2.1.1 CB-0601
        2.1.2 CJM-112
        2.1.3 CLS-007
        2.1.4 Dapsone
        2.1.5 DFD-10
        2.1.6 DLX-2323
        2.1.7 Others
    2.2 Global Acne Vulgaris Treatment Market Size by Type (2017, 2022 & 2028)
    2.3 Global Acne Vulgaris Treatment Market Size by Type (2017-2028)
    2.4 United States Acne Vulgaris Treatment Market Size by Type (2017, 2022 & 2028)
    2.5 United States Acne Vulgaris Treatment Market Size by Type (2017-2028)
3 Acne Vulgaris Treatment by Application
    3.1 Acne Vulgaris Treatment Market Segment by Application
        3.1.1 Clinic
        3.1.2 Hospital
        3.1.3 Others
    3.2 Global Acne Vulgaris Treatment Market Size by Application (2017, 2022 & 2028)
    3.3 Global Acne Vulgaris Treatment Market Size by Application (2017-2028)
    3.4 United States Acne Vulgaris Treatment Market Size by Application (2017, 2022 & 2028)
    3.5 United States Acne Vulgaris Treatment Market Size by Application (2017-2028)
4 Global Acne Vulgaris Treatment Competitor Landscape by Company
    4.1 Global Acne Vulgaris Treatment Market Size by Company
        4.1.1 Top Global Acne Vulgaris Treatment Companies Ranked by Revenue (2021)
        4.1.2 Global Acne Vulgaris Treatment Revenue by Player (2017-2022)
    4.2 Global Acne Vulgaris Treatment Concentration Ratio (CR)
        4.2.1 Acne Vulgaris Treatment Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Acne Vulgaris Treatment in 2021
        4.2.3 Global Acne Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Acne Vulgaris Treatment Headquarters, Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Acne Vulgaris Treatment Headquarters and Area Served
        4.3.2 Global Acne Vulgaris Treatment Companies Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Acne Vulgaris Treatment Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Acne Vulgaris Treatment Market Size by Company
        4.5.1 Top Acne Vulgaris Treatment Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Acne Vulgaris Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Acne Vulgaris Treatment Market Size by Region
    5.1 Global Acne Vulgaris Treatment Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Acne Vulgaris Treatment Market Size by Region (2017-2028)
        5.2.1 Global Acne Vulgaris Treatment Market Size by Region: 2017-2022
        5.2.2 Global Acne Vulgaris Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Acne Vulgaris Treatment Market Size YoY Growth 2017-2028
        6.1.2 North America Acne Vulgaris Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Acne Vulgaris Treatment Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Acne Vulgaris Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Acne Vulgaris Treatment Market Size YoY Growth 2017-2028
        6.3.2 Europe Acne Vulgaris Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Acne Vulgaris Treatment Market Size YoY Growth 2017-2028
        6.4.2 Latin America Acne Vulgaris Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Acne Vulgaris Treatment Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Acne Vulgaris Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Common Pharma Inc
        7.1.1 Common Pharma Inc Company Details
        7.1.2 Common Pharma Inc Business Overview
        7.1.3 Common Pharma Inc Acne Vulgaris Treatment Introduction
        7.1.4 Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.1.5 Common Pharma Inc Recent Development
    7.2 Cutanea Life Sciences Inc
        7.2.1 Cutanea Life Sciences Inc Company Details
        7.2.2 Cutanea Life Sciences Inc Business Overview
        7.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Introduction
        7.2.4 Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.2.5 Cutanea Life Sciences Inc Recent Development
    7.3 Dermira Inc
        7.3.1 Dermira Inc Company Details
        7.3.2 Dermira Inc Business Overview
        7.3.3 Dermira Inc Acne Vulgaris Treatment Introduction
        7.3.4 Dermira Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.3.5 Dermira Inc Recent Development
    7.4 ELORAC Inc
        7.4.1 ELORAC Inc Company Details
        7.4.2 ELORAC Inc Business Overview
        7.4.3 ELORAC Inc Acne Vulgaris Treatment Introduction
        7.4.4 ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.4.5 ELORAC Inc Recent Development
    7.5 Ensol Biosciences Inc
        7.5.1 Ensol Biosciences Inc Company Details
        7.5.2 Ensol Biosciences Inc Business Overview
        7.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Introduction
        7.5.4 Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.5.5 Ensol Biosciences Inc Recent Development
    7.6 Foamix Pharmaceuticals Ltd
        7.6.1 Foamix Pharmaceuticals Ltd Company Details
        7.6.2 Foamix Pharmaceuticals Ltd Business Overview
        7.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Introduction
        7.6.4 Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.6.5 Foamix Pharmaceuticals Ltd Recent Development
    7.7 Galderma SA
        7.7.1 Galderma SA Company Details
        7.7.2 Galderma SA Business Overview
        7.7.3 Galderma SA Acne Vulgaris Treatment Introduction
        7.7.4 Galderma SA Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.7.5 Galderma SA Recent Development
    7.8 GlaxoSmithKline Plc
        7.8.1 GlaxoSmithKline Plc Company Details
        7.8.2 GlaxoSmithKline Plc Business Overview
        7.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Introduction
        7.8.4 GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.8.5 GlaxoSmithKline Plc Recent Development
    7.9 Helix BioMedix Inc
        7.9.1 Helix BioMedix Inc Company Details
        7.9.2 Helix BioMedix Inc Business Overview
        7.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Introduction
        7.9.4 Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.9.5 Helix BioMedix Inc Recent Development
    7.10 Hovione FarmaCiencia SA
        7.10.1 Hovione FarmaCiencia SA Company Details
        7.10.2 Hovione FarmaCiencia SA Business Overview
        7.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Introduction
        7.10.4 Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.10.5 Hovione FarmaCiencia SA Recent Development
    7.11 Lee's Pharmaceutical Holdings Ltd
        7.11.1 Lee's Pharmaceutical Holdings Ltd Company Details
        7.11.2 Lee's Pharmaceutical Holdings Ltd Business Overview
        7.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Introduction
        7.11.4 Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.11.5 Lee's Pharmaceutical Holdings Ltd Recent Development
    7.12 LEO Pharma A/S
        7.12.1 LEO Pharma A/S Company Details
        7.12.2 LEO Pharma A/S Business Overview
        7.12.3 LEO Pharma A/S Acne Vulgaris Treatment Introduction
        7.12.4 LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.12.5 LEO Pharma A/S Recent Development
    7.13 Novabiotics Ltd
        7.13.1 Novabiotics Ltd Company Details
        7.13.2 Novabiotics Ltd Business Overview
        7.13.3 Novabiotics Ltd Acne Vulgaris Treatment Introduction
        7.13.4 Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.13.5 Novabiotics Ltd Recent Development
    7.14 Novan Inc
        7.14.1 Novan Inc Company Details
        7.14.2 Novan Inc Business Overview
        7.14.3 Novan Inc Acne Vulgaris Treatment Introduction
        7.14.4 Novan Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.14.5 Novan Inc Recent Development
    7.15 Novartis AG
        7.15.1 Novartis AG Company Details
        7.15.2 Novartis AG Business Overview
        7.15.3 Novartis AG Acne Vulgaris Treatment Introduction
        7.15.4 Novartis AG Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.15.5 Novartis AG Recent Development
    7.16 Paratek Pharmaceuticals Inc
        7.16.1 Paratek Pharmaceuticals Inc Company Details
        7.16.2 Paratek Pharmaceuticals Inc Business Overview
        7.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Introduction
        7.16.4 Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.16.5 Paratek Pharmaceuticals Inc Recent Development
    7.17 Pfizer Inc
        7.17.1 Pfizer Inc Company Details
        7.17.2 Pfizer Inc Business Overview
        7.17.3 Pfizer Inc Acne Vulgaris Treatment Introduction
        7.17.4 Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.17.5 Pfizer Inc Recent Development
    7.18 Phosphagenics Ltd
        7.18.1 Phosphagenics Ltd Company Details
        7.18.2 Phosphagenics Ltd Business Overview
        7.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Introduction
        7.18.4 Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2017-2022)
        7.18.5 Phosphagenics Ltd Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer
List of Tables
    Table 1. Acne Vulgaris Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Acne Vulgaris Treatment Market Trends
    Table 3. Acne Vulgaris Treatment Market Drivers
    Table 4. Acne Vulgaris Treatment Market Challenges
    Table 5. Acne Vulgaris Treatment Market Restraints
    Table 6. Global Acne Vulgaris Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Acne Vulgaris Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Acne Vulgaris Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Acne Vulgaris Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Acne Vulgaris Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Acne Vulgaris Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Acne Vulgaris Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Acne Vulgaris Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Acne Vulgaris Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris Treatment as of 2021)
    Table 15. Top Players of Acne Vulgaris Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Acne Vulgaris Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Acne Vulgaris Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Acne Vulgaris Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Acne Vulgaris Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Acne Vulgaris Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Acne Vulgaris Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Acne Vulgaris Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Acne Vulgaris Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Acne Vulgaris Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Acne Vulgaris Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Acne Vulgaris Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Acne Vulgaris Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Common Pharma Inc Company Details
    Table 31. Common Pharma Inc Business Overview
    Table 32. Common Pharma Inc Acne Vulgaris Treatment Product
    Table 33. Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 34. Common Pharma Inc Recent Development
    Table 35. Cutanea Life Sciences Inc Company Details
    Table 36. Cutanea Life Sciences Inc Business Overview
    Table 37. Cutanea Life Sciences Inc Acne Vulgaris Treatment Product
    Table 38. Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 39. Cutanea Life Sciences Inc Recent Development
    Table 40. Dermira Inc Company Details
    Table 41. Dermira Inc Business Overview
    Table 42. Dermira Inc Acne Vulgaris Treatment Product
    Table 43. Dermira Inc Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 44. Dermira Inc Recent Development
    Table 45. ELORAC Inc Company Details
    Table 46. ELORAC Inc Business Overview
    Table 47. ELORAC Inc Acne Vulgaris Treatment Product
    Table 48. ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 49. ELORAC Inc Recent Development
    Table 50. Ensol Biosciences Inc Company Details
    Table 51. Ensol Biosciences Inc Business Overview
    Table 52. Ensol Biosciences Inc Acne Vulgaris Treatment Product
    Table 53. Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 54. Ensol Biosciences Inc Recent Development
    Table 55. Foamix Pharmaceuticals Ltd Company Details
    Table 56. Foamix Pharmaceuticals Ltd Business Overview
    Table 57. Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product
    Table 58. Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 59. Foamix Pharmaceuticals Ltd Recent Development
    Table 60. Galderma SA Company Details
    Table 61. Galderma SA Business Overview
    Table 62. Galderma SA Acne Vulgaris Treatment Product
    Table 63. Galderma SA Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 64. Galderma SA Recent Development
    Table 65. GlaxoSmithKline Plc Company Details
    Table 66. GlaxoSmithKline Plc Business Overview
    Table 67. GlaxoSmithKline Plc Acne Vulgaris Treatment Product
    Table 68. GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 69. GlaxoSmithKline Plc Recent Development
    Table 70. Helix BioMedix Inc Company Details
    Table 71. Helix BioMedix Inc Business Overview
    Table 72. Helix BioMedix Inc Acne Vulgaris Treatment Product
    Table 73. Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 74. Helix BioMedix Inc Recent Development
    Table 75. Hovione FarmaCiencia SA Company Details
    Table 76. Hovione FarmaCiencia SA Business Overview
    Table 77. Hovione FarmaCiencia SA Acne Vulgaris Treatment Product
    Table 78. Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 79. Hovione FarmaCiencia SA Recent Development
    Table 80. Lee's Pharmaceutical Holdings Ltd Company Details
    Table 81. Lee's Pharmaceutical Holdings Ltd Business Overview
    Table 82. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Product
    Table 83. Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 84. Lee's Pharmaceutical Holdings Ltd Recent Development
    Table 85. LEO Pharma A/S Company Details
    Table 86. LEO Pharma A/S Business Overview
    Table 87. LEO Pharma A/S Acne Vulgaris Treatment Product
    Table 88. LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 89. LEO Pharma A/S Recent Development
    Table 90. Novabiotics Ltd Company Details
    Table 91. Novabiotics Ltd Business Overview
    Table 92. Novabiotics Ltd Acne Vulgaris Treatment Product
    Table 93. Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 94. Novabiotics Ltd Recent Development
    Table 95. Novan Inc Company Details
    Table 96. Novan Inc Business Overview
    Table 97. Novan Inc Acne Vulgaris Treatment Product
    Table 98. Novan Inc Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 99. Novan Inc Recent Development
    Table 100. Novartis AG Company Details
    Table 101. Novartis AG Business Overview
    Table 102. Novartis AG Acne Vulgaris Treatment Product
    Table 103. Novartis AG Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 104. Novartis AG Recent Development
    Table 105. Paratek Pharmaceuticals Inc Company Details
    Table 106. Paratek Pharmaceuticals Inc Business Overview
    Table 107. Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Product
    Table 108. Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 109. Paratek Pharmaceuticals Inc Recent Development
    Table 110. Pfizer Inc Company Details
    Table 111. Pfizer Inc Business Overview
    Table 112. Pfizer Inc Acne Vulgaris Treatment Product
    Table 113. Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 114. Pfizer Inc Recent Development
    Table 115. Phosphagenics Ltd Company Details
    Table 116. Phosphagenics Ltd Business Overview
    Table 117. Phosphagenics Ltd Acne Vulgaris Treatment Product
    Table 118. Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2017-2022) & (US$ Million)
    Table 119. Phosphagenics Ltd Recent Development
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Acne Vulgaris Treatment Product Picture
    Figure 2. Global Acne Vulgaris Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Acne Vulgaris Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Acne Vulgaris Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Acne Vulgaris Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Acne Vulgaris Treatment Market Share in Global 2017-2028
    Figure 7. Acne Vulgaris Treatment Report Years Considered
    Figure 8. Product Picture of CB-0601
    Figure 9. Product Picture of CJM-112
    Figure 10. Product Picture of CLS-007
    Figure 11. Product Picture of Dapsone
    Figure 12. Product Picture of DFD-10
    Figure 13. Product Picture of DLX-2323
    Figure 14. Product Picture of Others
    Figure 15. Global Acne Vulgaris Treatment Market Share by Type in 2022 & 2028
    Figure 16. Global Acne Vulgaris Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. Global Acne Vulgaris Treatment Market Share by Type (2017-2028)
    Figure 18. United States Acne Vulgaris Treatment Market Share by Type in 2022 & 2028
    Figure 19. United States Acne Vulgaris Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 20. United States Acne Vulgaris Treatment Market Share by Type (2017-2028)
    Figure 21. Product Picture of Clinic
    Figure 22. Product Picture of Hospital
    Figure 23. Product Picture of Others
    Figure 24. Global Acne Vulgaris Treatment Market Share by Application in 2022 & 2028
    Figure 25. Global Acne Vulgaris Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. Global Acne Vulgaris Treatment Market Share by Application (2017-2028)
    Figure 27. United States Acne Vulgaris Treatment Market Share by Application in 2022 & 2028
    Figure 28. United States Acne Vulgaris Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 29. United States Acne Vulgaris Treatment Market Share by Application (2017-2028)
    Figure 30. North America Acne Vulgaris Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. U.S. Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Canada Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Europe Acne Vulgaris Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. Germany Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. France Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. U.K. Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Italy Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Russia Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific Acne Vulgaris Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 40. China Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Japan Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. South Korea Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. India Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Australia Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Taiwan Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Indonesia Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Thailand Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Malaysia Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Philippines Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Latin America Acne Vulgaris Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Mexico Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Brazil Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Argentina Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa Acne Vulgaris Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 55. Turkey Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. U.A.E Acne Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Common Pharma Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 59. Cutanea Life Sciences Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 60. Dermira Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 61. ELORAC Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 62. Ensol Biosciences Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 63. Foamix Pharmaceuticals Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 64. Galderma SA Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 65. GlaxoSmithKline Plc Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 66. Helix BioMedix Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 67. Hovione FarmaCiencia SA Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 68. Lee's Pharmaceutical Holdings Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 69. LEO Pharma A/S Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 70. Novabiotics Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 71. Novan Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 72. Novartis AG Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 73. Paratek Pharmaceuticals Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 74. Pfizer Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 75. Phosphagenics Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2017-2022)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira Inc
ELORAC Inc
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline Plc
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Novabiotics Ltd
Novan Inc
Novartis AG
Paratek Pharmaceuticals Inc
Pfizer Inc
Phosphagenics Ltd
Frequently Asked Questions
Acne Vulgaris Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acne Vulgaris Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acne Vulgaris Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports